<DOC>
	<DOCNO>NCT01555086</DOCNO>
	<brief_summary>This study examine Limited versus extend pelvic lymphadenectomy .</brief_summary>
	<brief_title>Prospective Study Compare Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy</brief_title>
	<detailed_description>This study mean show extension lymphadenectomy prostatectomy influence outcome patient . Patients indication prostatectomy due prostate cancer include . Both extension lymphadenectomy use hospital free choice . This study shell show one method effective .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>stamp bioptic secure prostate cancer intermediate high risk profile ( define GleasonScore 710 PSA &gt; 10 ng/ml ) locallyoperable tumor accord DRU/TRUS negative bone scan negative CT abdomen / pelvis general condition accord Karnofsky &gt; /= 80 % write consent patient adequate hematological , renal coagulation physiological function Patient compliance geographic proximity allow adequate followup Manifest secondary malignancy Secured metastasis histologically image Myocardial infarction stroke within last 6 month Existing major cardiovascular ( grade III IV accord NYHA ) , pulmonary ( pO2 &lt; 60 mmHg ) , renal , hepatic hematopoietic ( eg severe bone marrow aplasia ) diseases Severe active chronic infection ( eg po . HIVAb test , HBsAg detection serum / chronic hepatitis ) severe psychiatric disease prior chemotherapy ( allow preoperative antiandrogen therapy â‰¤ 3 month ) previous pelvic radiotherapy Patients close institution accord authority court decision People dependent relationship work relationship sponsor investigator simultaneous participation another clinical trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Lymphadenectomy</keyword>
	<keyword>Prostate cancer</keyword>
</DOC>